SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001140361-06-004967
Filing Date
2006-03-31
Accepted
2006-03-31 17:43:09
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA, INC. body_10ksb.htm 10KSB 1167770
2 EXHIBIT 21.1 ex21_1.htm EX-21.1 6286
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11840
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12080
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5920
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 6044
  Complete submission text file 0001140361-06-004967.txt   1211546
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-16929 | Film No.: 06730404
SIC: 2834 Pharmaceutical Preparations